This paper describes the evolution of written patient information on prescription drugs, FDA's patient package insert proposal and its revocation before its implementation in the early 1980s, the status of voluntary and government efforts since that time, and a review of current trends in this area.
The burgeoning practice of direct-to-consumer advertising of prescription drugs in the lay press is viewed within the context of these efforts.
This paper also reviews the current developments in certain FDA-regulated consumer products-over-the-counter drug labeling and nutrition labeling.
The current state of patient information in the United States is reviewed in light of programs to improve prescription drug counseling, and current research in this area is discussed.
Mots-clés Pascal : Médicament, Communication information, Information thérapeutique, Malade, Communication écrite, Notice, Etats Unis, Homme, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Drug, Information communication, Therapeutic information, Patient, Written communication, Technical instructions, United States, Human, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 95-0590232
Code Inist : 002B30A08. Création : 01/03/1996.